Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Handbook of Dystonia, Second Edition

Informa Healthcare, May 2012, Pages: 440


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

As many as 250,000 people in the US, and many million worldwide, are afflicted by dystonia, making it the third most common movement disorder following Essential Tremor and Parkinson's Disease.
Following a very successful first edition, the second edition of the Handbook of Dystonia continues to provide a wide-ranging overview of the latest research and developments regarding the pathogenesis, evaluation, and management of this debilitating disease. The new edition presents eight new chapters and significant updates to existing chapters. These new chapters reflect the growing research and development in this area and this book will continue to serve as an important reference text for neurologists, neurosurgeons, physiatrists, movement disorder specialists, and physicians working with dystonia patients.
Highlights of the second edition include:
- Four new chapters on OnabotulinumtoxinA – Botox©, RimabotulinumtoxinB – Myobloc™, abobotulinumtoxinA – Dysport©, and incobotulinumtoxinA – Xeomin©, approved to treat dystonia



- A new chapter on transcranial magnetic stimulation (TMS)



- New chapters on Evaluation and Treatment of Spasticity and the role of phenol in treating spasticity and dystonia



- A new chapters on dystonic symptoms associated with Parkinsonian disorders



- Substantial updates to chapters on the genetic factors associated with of dystonia, as well as in-depth coverage of the neuroanatomy, neurophysiology, and neuropathology of this disease.
About the editor
Mark Stacy is Professor of Neurology, and Vice Dean of Clinical Research at Duke University Medical Center in Durham, North Carolina. Professor Stacy graduated with a MD degree from the University of Missouri, Columbia and completed his neurology residency at Hahnemann University in Philadelphia, Pennsylvania, before completing his Fellowship in Movement Disorders at Baylor College of Medicine. He is a member of many organizations including the American Academy of Neurology, the American Neurological Association and Movement Disorders Society, where he serves as co-editor of the society newsletter, Moving Along.





For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds